您的位置: 首页 > 农业专利 > 详情页

TARGETED DISRUPTION OF T CELL AND/OR HLA RECEPTORS
专利权人:
Sangamo Therapeutics; Inc.
发明人:
Anthony Conway,Sumiti Jain,Gary K. Lee,David Paschon,Edward J. Rebar,Lei Zhang
申请号:
US16009975
公开号:
US20180362926A1
申请日:
2018.06.15
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Disclosed herein are methods and compositions for inactivating TCR and/or HLA genes, using engineered nucleases comprising at least one DNA binding domain and a cleavage domain or cleavage half-domain in conditions able to preserve cell viability. Polynucleotides encoding nucleases, vectors comprising polynucleotides encoding nucleases and cells comprising polynucleotides encoding nucleases and/or cells comprising nucleases are also provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充